RS-56812: Difference between revisions
CSV import |
CSV import |
||
| Line 30: | Line 30: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:RS-56812 structure.png|RS-56812 Structure | |||
</gallery> | |||
Latest revision as of 01:28, 20 February 2025
RS-56812 is a drug that acts as a potent and selective 5-HT4 receptor agonist. It has been used in scientific research to explore the role of 5-HT4 receptors in the brain and gut, and produces a range of effects such as enhancing memory and counteracting the memory-impairing effects of scopolamine, increasing the release of acetylcholine in the brain, and stimulating gastric motility in the gut.
Pharmacology[edit]
RS-56812 is a potent and selective agonist for the 5-HT4 receptor, a type of serotonin receptor found in the brain and gut. It has a high affinity for this receptor, and its effects are thought to be mediated primarily through this interaction.
Brain[edit]
In the brain, RS-56812 has been shown to enhance memory and counteract the memory-impairing effects of scopolamine, a drug that blocks the action of acetylcholine. This suggests that RS-56812 may increase the release of acetylcholine in the brain, a neurotransmitter that is involved in memory and learning.
Gut[edit]
In the gut, RS-56812 has been shown to stimulate gastric motility, the movement of food through the digestive tract. This effect is thought to be mediated through the activation of 5-HT4 receptors in the gut.
Research uses[edit]
RS-56812 has been used in scientific research to explore the role of 5-HT4 receptors in the brain and gut. It has been used in studies investigating the effects of 5-HT4 receptor activation on memory and learning, as well as on gastric motility.
